Cryo-Cell International 股东年会表决四名董事选举及审计师任命等事项

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

CRYO-CELL INTERNATIONAL, INC.

(Exact name of Registrant as Specified in Its Charter)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

On October 27, 2026, Cryo-Cell International, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, stockholders voted on the election of four directors, the ratification of the appointment of WIPFLI LLC as the Company’s independent registered public accounting firm for the fiscal year ending November 30, 2026, and a non-binding advisory resolution regarding the compensation of the Company’s named executive officers.

The final voting results for each matter submitted to a vote at the Annual Meeting are set forth below.

1. Election of the Company's Board of Directors.

David Portnoy

For 6,474,964

Withhold 1,215,273

Harold Berger

For 7,121,908

Withhold 568,329

Mark Portnoy

For 6,496,862

Withhold 1,193,375

Daniel Mizrahi

For 7,152,068

Withhold 538,169

2. Ratification of the appointment of WIPFLI LLC as the Company's independent registered public accounting firm for the fiscal year ending November 30, 2026.

For Against Abstain

7,578,019 4,178 108,040

3. Approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers.

For Against Abstain

6,661,012 1,028,359 866

4. Authorization to vote the proxies upon other business properly coming before the Meeting or any adjournments or postponements thereof.

For Against Abstain

6,513,018 515,442 661,777

.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.